Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Growth 2026-2032
The global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Porcine viral diarrhea is a common and frequently-occurring disease in pigs, and the most serious pathogens are porcine transmissible gastroenteritis virus (TGEV), porcine epidemic diarrhea virus (PEDV) and porcine rotavirus (PoRV). All three pathogens can infect pigs of all ages and can cause symptoms such as vomiting, watery diarrhea and dehydration. The harm to piglets within 10 days of age is particularly serious, and the morbidity and mortality are high, up to 100%. The vaccine is inoculated at the Houhai point, and it is safe and effective for all pigs including suckling piglets and pregnant sows. It realizes the prevention of three diseases with one shot, reduces the immune stress of pigs, and reduces the labor intensity and breeding of vaccination. cost, and has a significant effect on the prevention of single infection or mixed infection of the three pathogens.
United States market for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine players cover Zoetis Animal Health, Boehringer-Ingelheim, Merck Animal Health, Ceva Sant? Animale, MSD Animal Health, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Industry Forecast? looks at past sales and reviews total world Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine sales for 2026 through 2032. With Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Porcine viral diarrhea is a common and frequently-occurring disease in pigs, and the most serious pathogens are porcine transmissible gastroenteritis virus (TGEV), porcine epidemic diarrhea virus (PEDV) and porcine rotavirus (PoRV). All three pathogens can infect pigs of all ages and can cause symptoms such as vomiting, watery diarrhea and dehydration. The harm to piglets within 10 days of age is particularly serious, and the morbidity and mortality are high, up to 100%. The vaccine is inoculated at the Houhai point, and it is safe and effective for all pigs including suckling piglets and pregnant sows. It realizes the prevention of three diseases with one shot, reduces the immune stress of pigs, and reduces the labor intensity and breeding of vaccination. cost, and has a significant effect on the prevention of single infection or mixed infection of the three pathogens.
United States market for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine players cover Zoetis Animal Health, Boehringer-Ingelheim, Merck Animal Health, Ceva Sant? Animale, MSD Animal Health, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Industry Forecast? looks at past sales and reviews total world Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine sales for 2026 through 2032. With Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Live Vaccine
- Inactivated Vaccine
- Piglets
- Adults Pigs
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Zoetis Animal Health
- Boehringer-Ingelheim
- Merck Animal Health
- Ceva Sant? Animale
- MSD Animal Health
- SPAH
- Nanjing Tianbang Biological Technology
- Sichuan Huapai Bio-pharmaceutical
- Guangdong Winsun Bio Pharmaceutical
- Wuhan Keqian Biology
- Shanghai Hile Bio-Technology
- Harbin Pharmaceutical Group Bio-Vaccine
- Ringpu
- Shandong Huahong Bioengineering
- Weike Biotechnology
- Nanjing Tianbang Biological Technology
- China Animal Husbandry Industry
- What is the 10-year outlook for the global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market?
- What factors are driving Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market opportunities vary by end market size?
- How does Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Segment by Type
2.2.1 Live Vaccine
2.2.2 Inactivated Vaccine
2.2.3 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Type
2.2.3.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sale Price by Type (2021-2026)
2.3 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Segment by Application
2.3.1 Piglets
2.3.2 Adults Pigs
2.3.3 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Application
2.3.3.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Breakdown Data by Company
3.1.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Company (2021-2026)
3.2.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sale Price by Company
3.4 Key Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Location Distribution
3.4.2 Players Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SWINE TRANSMISSBLE GASTROENTERITIS,PORCINE EPIDEMIC DIARRHEA AND PORCINE ROTAVIRUS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Growth
4.4 APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Growth
4.5 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Growth
4.6 Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Growth
5 AMERICAS
5.1 Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country
5.1.1 Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country (2021-2026)
5.1.2 Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country (2021-2026)
5.2 Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Type (2021-2026)
5.3 Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Region
6.1.1 APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Region (2021-2026)
6.1.2 APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Region (2021-2026)
6.2 APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Type (2021-2026)
6.3 APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine by Country
7.1.1 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country (2021-2026)
7.1.2 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country (2021-2026)
7.2 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Type (2021-2026)
7.3 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine by Country
8.1.1 Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine
10.3 Manufacturing Process Analysis of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine
10.4 Industry Chain Structure of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Distributors
11.3 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Customer
12 WORLD FORECAST REVIEW FOR SWINE TRANSMISSBLE GASTROENTERITIS,PORCINE EPIDEMIC DIARRHEA AND PORCINE ROTAVIRUS VACCINE BY GEOGRAPHIC REGION
12.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Size Forecast by Region
12.1.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Forecast by Region (2027-2032)
12.1.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Forecast by Type (2027-2032)
12.7 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Zoetis Animal Health
13.1.1 Zoetis Animal Health Company Information
13.1.2 Zoetis Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.1.3 Zoetis Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Zoetis Animal Health Main Business Overview
13.1.5 Zoetis Animal Health Latest Developments
13.2 Boehringer-Ingelheim
13.2.1 Boehringer-Ingelheim Company Information
13.2.2 Boehringer-Ingelheim Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.2.3 Boehringer-Ingelheim Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Boehringer-Ingelheim Main Business Overview
13.2.5 Boehringer-Ingelheim Latest Developments
13.3 Merck Animal Health
13.3.1 Merck Animal Health Company Information
13.3.2 Merck Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.3.3 Merck Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Merck Animal Health Main Business Overview
13.3.5 Merck Animal Health Latest Developments
13.4 Ceva Sant? Animale
13.4.1 Ceva Sant? Animale Company Information
13.4.2 Ceva Sant? Animale Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.4.3 Ceva Sant? Animale Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Ceva Sant? Animale Main Business Overview
13.4.5 Ceva Sant? Animale Latest Developments
13.5 MSD Animal Health
13.5.1 MSD Animal Health Company Information
13.5.2 MSD Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.5.3 MSD Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 MSD Animal Health Main Business Overview
13.5.5 MSD Animal Health Latest Developments
13.6 SPAH
13.6.1 SPAH Company Information
13.6.2 SPAH Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.6.3 SPAH Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 SPAH Main Business Overview
13.6.5 SPAH Latest Developments
13.7 Nanjing Tianbang Biological Technology
13.7.1 Nanjing Tianbang Biological Technology Company Information
13.7.2 Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.7.3 Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Nanjing Tianbang Biological Technology Main Business Overview
13.7.5 Nanjing Tianbang Biological Technology Latest Developments
13.8 Sichuan Huapai Bio-pharmaceutical
13.8.1 Sichuan Huapai Bio-pharmaceutical Company Information
13.8.2 Sichuan Huapai Bio-pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.8.3 Sichuan Huapai Bio-pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Sichuan Huapai Bio-pharmaceutical Main Business Overview
13.8.5 Sichuan Huapai Bio-pharmaceutical Latest Developments
13.9 Guangdong Winsun Bio Pharmaceutical
13.9.1 Guangdong Winsun Bio Pharmaceutical Company Information
13.9.2 Guangdong Winsun Bio Pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.9.3 Guangdong Winsun Bio Pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Guangdong Winsun Bio Pharmaceutical Main Business Overview
13.9.5 Guangdong Winsun Bio Pharmaceutical Latest Developments
13.10 Wuhan Keqian Biology
13.10.1 Wuhan Keqian Biology Company Information
13.10.2 Wuhan Keqian Biology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.10.3 Wuhan Keqian Biology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Wuhan Keqian Biology Main Business Overview
13.10.5 Wuhan Keqian Biology Latest Developments
13.11 Shanghai Hile Bio-Technology
13.11.1 Shanghai Hile Bio-Technology Company Information
13.11.2 Shanghai Hile Bio-Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.11.3 Shanghai Hile Bio-Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Shanghai Hile Bio-Technology Main Business Overview
13.11.5 Shanghai Hile Bio-Technology Latest Developments
13.12 Harbin Pharmaceutical Group Bio-Vaccine
13.12.1 Harbin Pharmaceutical Group Bio-Vaccine Company Information
13.12.2 Harbin Pharmaceutical Group Bio-Vaccine Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.12.3 Harbin Pharmaceutical Group Bio-Vaccine Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Harbin Pharmaceutical Group Bio-Vaccine Main Business Overview
13.12.5 Harbin Pharmaceutical Group Bio-Vaccine Latest Developments
13.13 Ringpu
13.13.1 Ringpu Company Information
13.13.2 Ringpu Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.13.3 Ringpu Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Ringpu Main Business Overview
13.13.5 Ringpu Latest Developments
13.14 Shandong Huahong Bioengineering
13.14.1 Shandong Huahong Bioengineering Company Information
13.14.2 Shandong Huahong Bioengineering Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.14.3 Shandong Huahong Bioengineering Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Shandong Huahong Bioengineering Main Business Overview
13.14.5 Shandong Huahong Bioengineering Latest Developments
13.15 Weike Biotechnology
13.15.1 Weike Biotechnology Company Information
13.15.2 Weike Biotechnology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.15.3 Weike Biotechnology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Weike Biotechnology Main Business Overview
13.15.5 Weike Biotechnology Latest Developments
13.16 Nanjing Tianbang Biological Technology
13.16.1 Nanjing Tianbang Biological Technology Company Information
13.16.2 Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.16.3 Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Nanjing Tianbang Biological Technology Main Business Overview
13.16.5 Nanjing Tianbang Biological Technology Latest Developments
13.17 China Animal Husbandry Industry
13.17.1 China Animal Husbandry Industry Company Information
13.17.2 China Animal Husbandry Industry Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.17.3 China Animal Husbandry Industry Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 China Animal Husbandry Industry Main Business Overview
13.17.5 China Animal Husbandry Industry Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
@LOT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Segment by Type
2.2.1 Live Vaccine
2.2.2 Inactivated Vaccine
2.2.3 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Type
2.2.3.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sale Price by Type (2021-2026)
2.3 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Segment by Application
2.3.1 Piglets
2.3.2 Adults Pigs
2.3.3 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Application
2.3.3.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Breakdown Data by Company
3.1.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Company (2021-2026)
3.2.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sale Price by Company
3.4 Key Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Location Distribution
3.4.2 Players Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SWINE TRANSMISSBLE GASTROENTERITIS,PORCINE EPIDEMIC DIARRHEA AND PORCINE ROTAVIRUS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Growth
4.4 APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Growth
4.5 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Growth
4.6 Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Growth
5 AMERICAS
5.1 Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country
5.1.1 Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country (2021-2026)
5.1.2 Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country (2021-2026)
5.2 Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Type (2021-2026)
5.3 Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Region
6.1.1 APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Region (2021-2026)
6.1.2 APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Region (2021-2026)
6.2 APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Type (2021-2026)
6.3 APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine by Country
7.1.1 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country (2021-2026)
7.1.2 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country (2021-2026)
7.2 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Type (2021-2026)
7.3 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine by Country
8.1.1 Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine
10.3 Manufacturing Process Analysis of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine
10.4 Industry Chain Structure of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Distributors
11.3 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Customer
12 WORLD FORECAST REVIEW FOR SWINE TRANSMISSBLE GASTROENTERITIS,PORCINE EPIDEMIC DIARRHEA AND PORCINE ROTAVIRUS VACCINE BY GEOGRAPHIC REGION
12.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Size Forecast by Region
12.1.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Forecast by Region (2027-2032)
12.1.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Forecast by Type (2027-2032)
12.7 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Zoetis Animal Health
13.1.1 Zoetis Animal Health Company Information
13.1.2 Zoetis Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.1.3 Zoetis Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Zoetis Animal Health Main Business Overview
13.1.5 Zoetis Animal Health Latest Developments
13.2 Boehringer-Ingelheim
13.2.1 Boehringer-Ingelheim Company Information
13.2.2 Boehringer-Ingelheim Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.2.3 Boehringer-Ingelheim Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Boehringer-Ingelheim Main Business Overview
13.2.5 Boehringer-Ingelheim Latest Developments
13.3 Merck Animal Health
13.3.1 Merck Animal Health Company Information
13.3.2 Merck Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.3.3 Merck Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Merck Animal Health Main Business Overview
13.3.5 Merck Animal Health Latest Developments
13.4 Ceva Sant? Animale
13.4.1 Ceva Sant? Animale Company Information
13.4.2 Ceva Sant? Animale Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.4.3 Ceva Sant? Animale Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Ceva Sant? Animale Main Business Overview
13.4.5 Ceva Sant? Animale Latest Developments
13.5 MSD Animal Health
13.5.1 MSD Animal Health Company Information
13.5.2 MSD Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.5.3 MSD Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 MSD Animal Health Main Business Overview
13.5.5 MSD Animal Health Latest Developments
13.6 SPAH
13.6.1 SPAH Company Information
13.6.2 SPAH Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.6.3 SPAH Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 SPAH Main Business Overview
13.6.5 SPAH Latest Developments
13.7 Nanjing Tianbang Biological Technology
13.7.1 Nanjing Tianbang Biological Technology Company Information
13.7.2 Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.7.3 Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Nanjing Tianbang Biological Technology Main Business Overview
13.7.5 Nanjing Tianbang Biological Technology Latest Developments
13.8 Sichuan Huapai Bio-pharmaceutical
13.8.1 Sichuan Huapai Bio-pharmaceutical Company Information
13.8.2 Sichuan Huapai Bio-pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.8.3 Sichuan Huapai Bio-pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Sichuan Huapai Bio-pharmaceutical Main Business Overview
13.8.5 Sichuan Huapai Bio-pharmaceutical Latest Developments
13.9 Guangdong Winsun Bio Pharmaceutical
13.9.1 Guangdong Winsun Bio Pharmaceutical Company Information
13.9.2 Guangdong Winsun Bio Pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.9.3 Guangdong Winsun Bio Pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Guangdong Winsun Bio Pharmaceutical Main Business Overview
13.9.5 Guangdong Winsun Bio Pharmaceutical Latest Developments
13.10 Wuhan Keqian Biology
13.10.1 Wuhan Keqian Biology Company Information
13.10.2 Wuhan Keqian Biology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.10.3 Wuhan Keqian Biology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Wuhan Keqian Biology Main Business Overview
13.10.5 Wuhan Keqian Biology Latest Developments
13.11 Shanghai Hile Bio-Technology
13.11.1 Shanghai Hile Bio-Technology Company Information
13.11.2 Shanghai Hile Bio-Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.11.3 Shanghai Hile Bio-Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Shanghai Hile Bio-Technology Main Business Overview
13.11.5 Shanghai Hile Bio-Technology Latest Developments
13.12 Harbin Pharmaceutical Group Bio-Vaccine
13.12.1 Harbin Pharmaceutical Group Bio-Vaccine Company Information
13.12.2 Harbin Pharmaceutical Group Bio-Vaccine Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.12.3 Harbin Pharmaceutical Group Bio-Vaccine Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Harbin Pharmaceutical Group Bio-Vaccine Main Business Overview
13.12.5 Harbin Pharmaceutical Group Bio-Vaccine Latest Developments
13.13 Ringpu
13.13.1 Ringpu Company Information
13.13.2 Ringpu Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.13.3 Ringpu Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Ringpu Main Business Overview
13.13.5 Ringpu Latest Developments
13.14 Shandong Huahong Bioengineering
13.14.1 Shandong Huahong Bioengineering Company Information
13.14.2 Shandong Huahong Bioengineering Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.14.3 Shandong Huahong Bioengineering Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Shandong Huahong Bioengineering Main Business Overview
13.14.5 Shandong Huahong Bioengineering Latest Developments
13.15 Weike Biotechnology
13.15.1 Weike Biotechnology Company Information
13.15.2 Weike Biotechnology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.15.3 Weike Biotechnology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Weike Biotechnology Main Business Overview
13.15.5 Weike Biotechnology Latest Developments
13.16 Nanjing Tianbang Biological Technology
13.16.1 Nanjing Tianbang Biological Technology Company Information
13.16.2 Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.16.3 Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Nanjing Tianbang Biological Technology Main Business Overview
13.16.5 Nanjing Tianbang Biological Technology Latest Developments
13.17 China Animal Husbandry Industry
13.17.1 China Animal Husbandry Industry Company Information
13.17.2 China Animal Husbandry Industry Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.17.3 China Animal Husbandry Industry Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 China Animal Husbandry Industry Main Business Overview
13.17.5 China Animal Husbandry Industry Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
@LOT
LIST OF TABLES
Table 1. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Live Vaccine
Table 4. Major Players of Inactivated Vaccine
Table 5. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Type (2021-2026) & (K Doses)
Table 6. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sale Price by Type (2021-2026) & (US$/Dose)
Table 10. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sale by Application (2021-2026) & (K Doses)
Table 11. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sale Price by Application (2021-2026) & (US$/Dose)
Table 15. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Company (2021-2026) & (K Doses)
Table 16. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sale Price by Company (2021-2026) & (US$/Dose)
Table 20. Key Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Producing Area Distribution and Sales Area
Table 21. Players Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Products Offered
Table 22. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Geographic Region (2021-2026) & (K Doses)
Table 26. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country/Region (2021-2026) & (K Doses)
Table 30. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country (2021-2026) & (K Doses)
Table 34. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Type (2021-2026) & (K Doses)
Table 37. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Application (2021-2026) & (K Doses)
Table 38. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Region (2021-2026) & (K Doses)
Table 39. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Type (2021-2026) & (K Doses)
Table 42. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Application (2021-2026) & (K Doses)
Table 43. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country (2021-2026) & (K Doses)
Table 44. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Type (2021-2026) & (K Doses)
Table 46. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Application (2021-2026) & (K Doses)
Table 47. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country (2021-2026) & (K Doses)
Table 48. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Type (2021-2026) & (K Doses)
Table 50. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Application (2021-2026) & (K Doses)
Table 51. Key Market Drivers & Growth Opportunities of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine
Table 52. Key Market Challenges & Risks of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine
Table 53. Key Industry Trends of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine
Table 54. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Distributors List
Table 57. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Customer List
Table 58. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Forecast by Region (2027-2032) & (K Doses)
Table 59. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Doses)
Table 61. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Forecast by Region (2027-2032) & (K Doses)
Table 63. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Doses)
Table 65. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Doses)
Table 67. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Forecast by Type (2027-2032) & (K Doses)
Table 69. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Forecast by Application (2027-2032) & (K Doses)
Table 71. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Zoetis Animal Health Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Zoetis Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 74. Zoetis Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 75. Zoetis Animal Health Main Business
Table 76. Zoetis Animal Health Latest Developments
Table 77. Boehringer-Ingelheim Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Boehringer-Ingelheim Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 79. Boehringer-Ingelheim Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 80. Boehringer-Ingelheim Main Business
Table 81. Boehringer-Ingelheim Latest Developments
Table 82. Merck Animal Health Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Merck Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 84. Merck Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 85. Merck Animal Health Main Business
Table 86. Merck Animal Health Latest Developments
Table 87. Ceva Sant? Animale Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Ceva Sant? Animale Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 89. Ceva Sant? Animale Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 90. Ceva Sant? Animale Main Business
Table 91. Ceva Sant? Animale Latest Developments
Table 92. MSD Animal Health Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. MSD Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 94. MSD Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 95. MSD Animal Health Main Business
Table 96. MSD Animal Health Latest Developments
Table 97. SPAH Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. SPAH Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 99. SPAH Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 100. SPAH Main Business
Table 101. SPAH Latest Developments
Table 102. Nanjing Tianbang Biological Technology Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 104. Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 105. Nanjing Tianbang Biological Technology Main Business
Table 106. Nanjing Tianbang Biological Technology Latest Developments
Table 107. Sichuan Huapai Bio-pharmaceutical Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Sichuan Huapai Bio-pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 109. Sichuan Huapai Bio-pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 110. Sichuan Huapai Bio-pharmaceutical Main Business
Table 111. Sichuan Huapai Bio-pharmaceutical Latest Developments
Table 112. Guangdong Winsun Bio Pharmaceutical Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Guangdong Winsun Bio Pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 114. Guangdong Winsun Bio Pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 115. Guangdong Winsun Bio Pharmaceutical Main Business
Table 116. Guangdong Winsun Bio Pharmaceutical Latest Developments
Table 117. Wuhan Keqian Biology Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Wuhan Keqian Biology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 119. Wuhan Keqian Biology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 120. Wuhan Keqian Biology Main Business
Table 121. Wuhan Keqian Biology Latest Developments
Table 122. Shanghai Hile Bio-Technology Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Shanghai Hile Bio-Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 124. Shanghai Hile Bio-Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 125. Shanghai Hile Bio-Technology Main Business
Table 126. Shanghai Hile Bio-Technology Latest Developments
Table 127. Harbin Pharmaceutical Group Bio-Vaccine Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. Harbin Pharmaceutical Group Bio-Vaccine Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 129. Harbin Pharmaceutical Group Bio-Vaccine Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 130. Harbin Pharmaceutical Group Bio-Vaccine Main Business
Table 131. Harbin Pharmaceutical Group Bio-Vaccine Latest Developments
Table 132. Ringpu Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 133. Ringpu Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 134. Ringpu Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 135. Ringpu Main Business
Table 136. Ringpu Latest Developments
Table 137. Shandong Huahong Bioengineering Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 138. Shandong Huahong Bioengineering Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 139. Shandong Huahong Bioengineering Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 140. Shandong Huahong Bioengineering Main Business
Table 141. Shandong Huahong Bioengineering Latest Developments
Table 142. Weike Biotechnology Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 143. Weike Biotechnology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 144. Weike Biotechnology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 145. Weike Biotechnology Main Business
Table 146. Weike Biotechnology Latest Developments
Table 147. Nanjing Tianbang Biological Technology Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 148. Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 149. Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 150. Nanjing Tianbang Biological Technology Main Business
Table 151. Nanjing Tianbang Biological Technology Latest Developments
Table 152. China Animal Husbandry Industry Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 153. China Animal Husbandry Industry Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 154. China Animal Husbandry Industry Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 155. China Animal Husbandry Industry Main Business
Table 156. China Animal Husbandry Industry Latest Developments
Table 1. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Live Vaccine
Table 4. Major Players of Inactivated Vaccine
Table 5. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Type (2021-2026) & (K Doses)
Table 6. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sale Price by Type (2021-2026) & (US$/Dose)
Table 10. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sale by Application (2021-2026) & (K Doses)
Table 11. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sale Price by Application (2021-2026) & (US$/Dose)
Table 15. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Company (2021-2026) & (K Doses)
Table 16. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sale Price by Company (2021-2026) & (US$/Dose)
Table 20. Key Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Producing Area Distribution and Sales Area
Table 21. Players Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Products Offered
Table 22. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Geographic Region (2021-2026) & (K Doses)
Table 26. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country/Region (2021-2026) & (K Doses)
Table 30. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country (2021-2026) & (K Doses)
Table 34. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Type (2021-2026) & (K Doses)
Table 37. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Application (2021-2026) & (K Doses)
Table 38. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Region (2021-2026) & (K Doses)
Table 39. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Type (2021-2026) & (K Doses)
Table 42. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Application (2021-2026) & (K Doses)
Table 43. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country (2021-2026) & (K Doses)
Table 44. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Type (2021-2026) & (K Doses)
Table 46. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Application (2021-2026) & (K Doses)
Table 47. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country (2021-2026) & (K Doses)
Table 48. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Type (2021-2026) & (K Doses)
Table 50. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Application (2021-2026) & (K Doses)
Table 51. Key Market Drivers & Growth Opportunities of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine
Table 52. Key Market Challenges & Risks of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine
Table 53. Key Industry Trends of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine
Table 54. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Distributors List
Table 57. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Customer List
Table 58. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Forecast by Region (2027-2032) & (K Doses)
Table 59. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Doses)
Table 61. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Forecast by Region (2027-2032) & (K Doses)
Table 63. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Doses)
Table 65. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Doses)
Table 67. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Forecast by Type (2027-2032) & (K Doses)
Table 69. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Forecast by Application (2027-2032) & (K Doses)
Table 71. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Zoetis Animal Health Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Zoetis Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 74. Zoetis Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 75. Zoetis Animal Health Main Business
Table 76. Zoetis Animal Health Latest Developments
Table 77. Boehringer-Ingelheim Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Boehringer-Ingelheim Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 79. Boehringer-Ingelheim Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 80. Boehringer-Ingelheim Main Business
Table 81. Boehringer-Ingelheim Latest Developments
Table 82. Merck Animal Health Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Merck Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 84. Merck Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 85. Merck Animal Health Main Business
Table 86. Merck Animal Health Latest Developments
Table 87. Ceva Sant? Animale Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Ceva Sant? Animale Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 89. Ceva Sant? Animale Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 90. Ceva Sant? Animale Main Business
Table 91. Ceva Sant? Animale Latest Developments
Table 92. MSD Animal Health Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. MSD Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 94. MSD Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 95. MSD Animal Health Main Business
Table 96. MSD Animal Health Latest Developments
Table 97. SPAH Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. SPAH Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 99. SPAH Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 100. SPAH Main Business
Table 101. SPAH Latest Developments
Table 102. Nanjing Tianbang Biological Technology Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 104. Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 105. Nanjing Tianbang Biological Technology Main Business
Table 106. Nanjing Tianbang Biological Technology Latest Developments
Table 107. Sichuan Huapai Bio-pharmaceutical Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Sichuan Huapai Bio-pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 109. Sichuan Huapai Bio-pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 110. Sichuan Huapai Bio-pharmaceutical Main Business
Table 111. Sichuan Huapai Bio-pharmaceutical Latest Developments
Table 112. Guangdong Winsun Bio Pharmaceutical Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Guangdong Winsun Bio Pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 114. Guangdong Winsun Bio Pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 115. Guangdong Winsun Bio Pharmaceutical Main Business
Table 116. Guangdong Winsun Bio Pharmaceutical Latest Developments
Table 117. Wuhan Keqian Biology Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Wuhan Keqian Biology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 119. Wuhan Keqian Biology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 120. Wuhan Keqian Biology Main Business
Table 121. Wuhan Keqian Biology Latest Developments
Table 122. Shanghai Hile Bio-Technology Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Shanghai Hile Bio-Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 124. Shanghai Hile Bio-Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 125. Shanghai Hile Bio-Technology Main Business
Table 126. Shanghai Hile Bio-Technology Latest Developments
Table 127. Harbin Pharmaceutical Group Bio-Vaccine Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. Harbin Pharmaceutical Group Bio-Vaccine Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 129. Harbin Pharmaceutical Group Bio-Vaccine Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 130. Harbin Pharmaceutical Group Bio-Vaccine Main Business
Table 131. Harbin Pharmaceutical Group Bio-Vaccine Latest Developments
Table 132. Ringpu Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 133. Ringpu Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 134. Ringpu Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 135. Ringpu Main Business
Table 136. Ringpu Latest Developments
Table 137. Shandong Huahong Bioengineering Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 138. Shandong Huahong Bioengineering Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 139. Shandong Huahong Bioengineering Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 140. Shandong Huahong Bioengineering Main Business
Table 141. Shandong Huahong Bioengineering Latest Developments
Table 142. Weike Biotechnology Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 143. Weike Biotechnology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 144. Weike Biotechnology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 145. Weike Biotechnology Main Business
Table 146. Weike Biotechnology Latest Developments
Table 147. Nanjing Tianbang Biological Technology Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 148. Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 149. Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 150. Nanjing Tianbang Biological Technology Main Business
Table 151. Nanjing Tianbang Biological Technology Latest Developments
Table 152. China Animal Husbandry Industry Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 153. China Animal Husbandry Industry Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 154. China Animal Husbandry Industry Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 155. China Animal Husbandry Industry Main Business
Table 156. China Animal Husbandry Industry Latest Developments
LIST OF FIGURES
Figure 1. Picture of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine
Figure 2. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Growth Rate 2021-2032 (K Doses)
Figure 7. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Live Vaccine
Figure 12. Product Picture of Inactivated Vaccine
Figure 13. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Type in 2026
Figure 14. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumed in Piglets
Figure 16. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market: Piglets (2021-2026) & (K Doses)
Figure 17. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumed in Adults Pigs
Figure 18. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market: Adults Pigs (2021-2026) & (K Doses)
Figure 19. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sale Market Share by Application (2025)
Figure 20. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Application in 2026
Figure 21. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Company in 2026 (K Doses)
Figure 22. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Company in 2026
Figure 23. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Company in 2026 ($ millions)
Figure 24. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Company in 2026
Figure 25. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales 2021-2026 (K Doses)
Figure 28. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 29. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales 2021-2026 (K Doses)
Figure 30. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 31. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales 2021-2026 (K Doses)
Figure 32. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales 2021-2026 (K Doses)
Figure 34. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Country in 2026
Figure 36. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Country (2021-2026)
Figure 37. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 38. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 39. United States Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Region in 2026
Figure 44. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Region (2021-2026)
Figure 45. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 46. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 47. China Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. India Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Country in 2026
Figure 55. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Country (2021-2026)
Figure 56. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 57. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 58. Germany Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. France Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 66. Egypt Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine in 2026
Figure 72. Manufacturing Process Analysis of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine
Figure 73. Industry Chain Structure of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Forecast by Region (2027-2032)
Figure 1. Picture of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine
Figure 2. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Growth Rate 2021-2032 (K Doses)
Figure 7. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Live Vaccine
Figure 12. Product Picture of Inactivated Vaccine
Figure 13. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Type in 2026
Figure 14. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumed in Piglets
Figure 16. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market: Piglets (2021-2026) & (K Doses)
Figure 17. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumed in Adults Pigs
Figure 18. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market: Adults Pigs (2021-2026) & (K Doses)
Figure 19. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sale Market Share by Application (2025)
Figure 20. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Application in 2026
Figure 21. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Company in 2026 (K Doses)
Figure 22. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Company in 2026
Figure 23. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Company in 2026 ($ millions)
Figure 24. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Company in 2026
Figure 25. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales 2021-2026 (K Doses)
Figure 28. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 29. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales 2021-2026 (K Doses)
Figure 30. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 31. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales 2021-2026 (K Doses)
Figure 32. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales 2021-2026 (K Doses)
Figure 34. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Country in 2026
Figure 36. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Country (2021-2026)
Figure 37. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 38. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 39. United States Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Region in 2026
Figure 44. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Region (2021-2026)
Figure 45. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 46. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 47. China Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. India Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Country in 2026
Figure 55. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Country (2021-2026)
Figure 56. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 57. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 58. Germany Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. France Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 66. Egypt Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine in 2026
Figure 72. Manufacturing Process Analysis of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine
Figure 73. Industry Chain Structure of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Forecast by Region (2027-2032)
